Jesus Castro Marrero Jesús Castro is currently a Senior Postdoctoral Researcher linked to the Vall d'Hebron University Hospital Research Institute (VHIR) since 2000. In the last 20 years, Dr. Castro has dedicated themselves to basic research in autoimmune and rheumatic diseases with more than 50 publications and book chapters high impact He is currently the coordinator of the CFS/ME Research Laboratory at the Vall d'Hebron Hospital, in Barcelona, Spain. Institutions of which they are part Main researcher Rheumatology Vall Hebron Institut de Recerca Jesus Castro Marrero Institutions of which they are part Main researcher Rheumatology Vall Hebron Institut de Recerca Jesús Castro is currently a Senior Postdoctoral Researcher linked to the Vall d'Hebron University Hospital Research Institute (VHIR) since 2000. In the last 20 years, Dr. Castro has dedicated themselves to basic research in autoimmune and rheumatic diseases with more than 50 publications and book chapters high impact He is currently the coordinator of the CFS/ME Research Laboratory at the Vall d'Hebron Hospital, in Barcelona, Spain.
Jesus Castro earned his Postdoctoral Researcher Fellowship degree in Biochemistry and Molecular Biology program at the Valladolid University School of Medicine, Spain in 1999. Dr. Castro is currently a Senior Postdoctoral Research at the Vall d’Hebron Hospital Research Institute, University of Barcelona School of Medicine, Barcelona, Spain since 2002. In the past 20 years have been devoted to basic research of respiratory medicine, autoimmune and rheumatic conditions with over 50 high-impact factor publications and book chapters. He is currently the coordinator of the CFS/ME Research Laboratory at the Vall d'Hebron Hospital, in Barcelona, Spain. Dr. Castro is a member of the E.U. CFS/ME Research Collaborative Consortium Initiative (European Myalgic Encephalomyelitis NEtwork-EUROMENE). His current research is focused on the bioenergetic metabolism, mitochondrial dysfunction, and neuroimmune pathways linked to the immune response in CFS/ME, as well as finding useful biomarkers to aid in the diagnosis, treatment, and management of CFS/ME through clinical trials in order to improve prognosis and quality of life of CFS/ME patients.
Projects Lupus y Apoptosis: Mecanismo de acción de la talidomida y sus análogos en el lupus cutáneo refractario. Implicaciones clínicas y terapéuticas IP: Miguel Vilardell Tarres Collaborators: Vicente García-Patos Briones, Jesus Castro Marrero, Patricia Bassas Freixas Funding agency: Instituto de Salud Carlos III Funding: 13189 Reference: PI080112 Duration: 01/01/2009 - 31/12/2011 Asociación de alelos HLA-Clase II y susceptibilidad al asma ocupacional inducida por sustancias de bajo peso molecular: Isocianatos y sales de persulfatos. IP: Jesus Castro Marrero Collaborators: - Funding agency: Fundació Catalana de Pneumologia Funding: 9000 Reference: FUCAP/01/05 Duration: 01/01/2005 - 31/12/2006 Asociación de los alelos HLA clase II y riesgo de susceptibilidad en el asma ocupacional inducida por sustancias de bajo peso molecular en una población española: Implicaciones diagnósticas y terapéuticas IP: Mª Jesús Cruz Carmona Collaborators: Fco. Javier Muñoz Gall, Jesus Castro Marrero, Susana Gómez Olles Funding agency: Instituto de Salud Carlos III Funding: 26837.8 Reference: PI06/0256 Duration: 01/01/2007 - 30/06/2010 Patologia cel·lular IP: Anna Meseguer Navarro Collaborators: Joan López Hellin, Jesus Castro Marrero, Elisa Llurba Olivé Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: Reference: 2005SGR 01000 Duration: 01/01/2006 - 31/12/2008 Pagination First page « Previous page ‹ Page 1 Page 2 Current page 3
